Rick Pazdur, formerly the FDA’s top oncology official, said the FDA is at a critical juncture that could determine the direction of the world’s top regulator of medicines. Pazdur spoke during a STAT panel discussion during the annual meeting of the American Society of Clinical Oncology. The post Former FDA Officials: There’s Opportunity to Rebuild the Agency — But Not the Way It Was appeared first on MedCity News.

Peterson Philanthropies launched Peterson Health Analytics with a $50 million commitment to help employers better understand and manage healthcare costs. The post Peterson Philanthropies Unveils Employer Health Analytics Company via $50M Commitment appeared first on MedCity News.

Healthcare startup exits are improving but remain highly selective. Jack Euston, general partner Fountain Health Partners, expects the next exit cycle to reward AI-enabled, workflow-embedded companies while sidelining undifferentiated point solutions and growth-at-all-costs models. The post What Will the Next Healthcare Exit Winners Look Like? appeared first on MedCity News.

Options abound for hospitals looking to capitalize on these new data transfer technologies, but so do potential pitfalls. For any hospital considering adopting these new solutions, here are some of the key questions and considerations that should be top of mind. The post New Technology is Revolutionizing Clinical Trial Data Management — Here’s How Research Hospitals Can Seize the Moment appeared first on MedCity News.

Rural healthcare has always run on ingenuity, resilience, and community trust. What has too often been missing is the infrastructure strong enough to match that and sustain it at scale. That is what makes this moment different. The post Building the Backbone of Rural Health: Meeting the Reality on the Ground appeared first on MedCity News.

Portable gluten detection tools are not a substitute for standard care. Used carefully, they may help clinicians support patients when hidden gluten exposure remains a problem. The post The Celiac Care Gap Begins After Diagnosis appeared first on MedCity News.

Novellia raised $18 million in Series A funding to scale its platform, which helps patients consolidate medical records and share anonymized data with pharma companies. CEO Shashi Shankar argued that sourcing data directly from patients can create more complete healthcare datasets and improve drug research. The post Novellia Snags $18M for Its Real-World Data Platform  appeared first on MedCity News.

Ilant Health’s Series A round was led by Cornucopian Capital, with participation from naturalX, Peakbridge, Semcap AI, Evidenced, Operator Partners, Celtic, LifeX and AlphaLab. The post Ilant Health Raises $15M to Advance Obesity Care appeared first on MedCity News.

Fulcrum Therapeutics drug pociredir posted early clinical trial results showing signs of treating sickle cell disease with no reports of serious complications. But the biotech is discontinuing this program due to FDA concerns that drugs in this class of medicines raise the risk of cancer. The post FDA Concerns About Cancer Risk Sink Fulcrum Therapeutics’ Sickle Cell Disease Drug appeared first on MedCity News.

Timely, usable data closes care gaps and improves operations, but healthcare organizations lack access. The post What Data Delays Are Costing Healthcare — And Its Patients appeared first on MedCity News.

Access to AI-powered digital MSK care options reduces wait times and allows patients to move directly into the right care instead of stair-stepping from hospital inpatient to primary care physicians to physical therapy. The post AI for MSK Will Bend the Healthcare Cost Curve appeared first on MedCity News.

When used thoughtfully, with attention to muscle preservation and long-term sustainability, medical weight loss can lower complication rates, support a steadier recovery and reduce downstream strain on both patients and health systems. The post Medical Weight Loss is Rapidly Changing Surgical Risk and Costs appeared first on MedCity News.

France-based pharma company Servier is acquiring the muscular dystrophy business of Edgewise Therapeutics as part of a revenue growth strategy in oncology and neurology. The deal brings an Edgewise drug in clinical development for two rare neuromuscular disorders with limited treatment options. The post Servier Moves Into Muscular Dystrophy, Paying $1.5B for Assets From Edgewise Therapeutics appeared first on MedCity News.

The Massachusetts attorney general sued UnitedHealthcare, alleging the insurer improperly inflated MassHealth members’ health risk scores to secure at least $100 million in excess payments. The post Massachusetts Attorney General Sues UnitedHealthcare, Alleges $100M MassHealth Fraud appeared first on MedCity News.